Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9RWM

Crystal structure of human ADAMTS-5 Cb and Spacer domains

Summary for 9RWM
Entry DOI10.2210/pdb9rwm/pdb
DescriptorA disintegrin and metalloproteinase with thrombospondin motifs 5 (2 entities in total)
Functional Keywordsspacer domain, jelly-roll, cys rich domain, protein binding
Biological sourceHomo sapiens (human)
Total number of polymer chains3
Total formula weight64447.63
Authors
Milani, M.,Mastrangelo, E. (deposition date: 2025-07-09, release date: 2026-05-20)
Primary citationMilani, M.,Visintin, M.,Krastanova, I.,Visentini, M.,Margotti, E.,Ugolini, G.,Bolognesi, M.,Rovati, L.C.,Mastrangelo, E.
Structure, substrate recognition and therapeutic targeting of the human ADAMTS-5 spacer domain.
Acta Crystallogr D Struct Biol, 82:53-61, 2026
Cited by
PubMed Abstract: The ADAMTS (a disintegrin-like and metalloproteinase domain with thrombospondin type 1 motifs) family of secreted metalloproteinases plays essential roles in extracellular matrix remodeling. ADAMTS-5 contributes to cartilage degradation, cleaving proteoglycans such as aggrecan and versican, and being involved in both physiological tissue turnover and pathological processes such as osteoarthritis and atherosclerosis. Although structural insights into its catalytic domain have informed inhibitor development, the role of ancillary domains, particularly the spacer domain, in substrate recognition and specificity remains underexplored. Here, we report the crystal structure of a segment of human ADAMTS-5 encompassing the C-terminal portion of the cysteine-rich domain and the spacer domain (residues 694-876). This structure reveals critical features of the spacer domain, including the hypervariable loops that function as exosites essential for the binding of aggrecan and versican. Our findings provide new structural insights into the molecular determinants of the substrate specificity of ADAMTS-5 and underscore the spacer domain as a promising target for the development of selective inhibitors.
PubMed: 41334750
DOI: 10.1107/S2059798325010290
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

253795

PDB entries from 2026-05-20

PDB statisticsPDBj update infoContact PDBjnumon